Developing science,
delivering therapies

Our company

We are pioneers in harnessing bacteria as a revolutionary new class of medicines – called live biotherapeutics.

Our approach

Developing science

From asthma to cancer, we conduct world-leading research to identify live biotherapeutics with drug-like functionality to treat a range of diseases.

What we do

Delivering therapies

We are uniquely positioned to rapidly translate our research into regulated, safe and efficacious therapies for patients.

Find out more

News

4D pharma plc today announces that the Company has entered into a research collaboration and option to license agreement with MSD to discover and develop Live Biotherapeutics for vaccines
4D pharma announces the publication of data highlighting the neuroprotective properties of MRx0005 and MRx0029
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces the appointment of Sandy Macrae, PhD, as an independent Non-Executive Director with immediate effect.

BACK TO TOP